Effect of Uric Acid on the Development of Chronic Kidney Disease: The Korean Multi-Rural Communities Cohort Study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: Several studies have investigated the effects of serum uric acid (SUA) levels on chronic kidney disease (CKD), with discrepant results. The effect of SUA levels on CKD development was studied in the Korean rural population. Methods: A total of 9695 participants aged ≥40 years were recruited from 3 rural communities in Korea between 2005 and 2009. Of those participants, 5577 who participated in the follow-up and did not have cerebrovascular disease, myocardial infarction, cancer, or CKD at baseline were studied. The participants, of whom 2133 were men and 3444 were women, were grouped into 5 categories according to their quintile of SUA levels. An estimated glomerular filtration rate of <60 mL/min/1.73 m2 at the time of follow-up was considered to indicate newly developed CKD. The effects of SUA levels on CKD development after adjusting for potential confounders were assessed using Cox proportional hazard models. Results: Among the 5577 participants, 9.4 and 11.0% of men and women developed CKD. The hazard ratio (HR) of CKD was higher in the highest quintile of SUA levels than in the third quintile in men (adjusted HR, 1.60; 95% confidence interval [CI], 1.02 to 2.51) and women (adjusted HR, 1.56; 95% CI, 1.14 to 2.15). Furthermore, CKD development was also more common in the lowest quintile of SUA levels than in the third quintile in men (adjusted HR, 1.83; 95% CI, 1.15 to 2.90). The effect of SUA was consistent in younger, obese, and hypertensive men. Conclusions: Both high and low SUA levels were risk factors for CKD development in rural Korean men, while only high levels were a risk factor in their women counterparts.
Abstract
Objectives: Several studies have investigated the effects of serum uric acid (SUA) levels on chronic kidney disease (CKD), with discrepant results. The effect of SUA levels on CKD development was studied in the Korean rural population. Methods: A total of 9695 participants aged ≥40 years were recruited from 3 rural communities in Korea between 2005 and 2009. Of those participants, 5577 who participated in the follow-up and did not have cerebrovascular disease, myocardial infarction, cancer, or CKD at baseline were studied. The participants, of whom 2133 were men and 3444 were women, were grouped into 5 categories according to their quintile of SUA levels. An estimated glomerular filtration rate of <60 mL/min/1.73 m2 at the time of follow-up was considered to indicate newly developed CKD. The effects of SUA levels on CKD development after adjusting for potential confounders were assessed using Cox proportional hazard models. Results: Among the 5577 participants, 9.4 and 11.0% of men and women developed CKD. The hazard ratio (HR) of CKD was higher in the highest quintile of SUA levels than in the third quintile in men (adjusted HR, 1.60; 95% confidence interval [CI], 1.02 to 2.51) and women (adjusted HR, 1.56; 95% CI, 1.14 to 2.15). Furthermore, CKD development was also more common in the lowest quintile of SUA levels than in the third quintile in men (adjusted HR, 1.83; 95% CI, 1.15 to 2.90). The effect of SUA was consistent in younger, obese, and hypertensive men. Conclusions: Both high and low SUA levels were risk factors for CKD development in rural Korean men, while only high levels were a risk factor in their women counterparts.
참고문헌 (40)
- Couser WG, "The contribution of chronic kidney disease to the global burden of major noncommunicable diseases", Kidney Int, 80(12), pp.1258~1270 (2011)[DOI]
- 진동찬, "Lessons from 30 years’ data of Korean end-stage renal disease registry, 1985–2015", Kidney Research and Clinical Practice, 34(3), pp.132~139 (2015), 대한신장학회
- 박지인, "Prevalence of Chronic Kidney Disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013", Journal of Korean Medical Science, 31(6), pp.915~923 (2016), 대한의학회
- Iseki K, "Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort", Am J Kidney Dis, 44(4), pp.642~650 (2004)[DOI]
- Hakoda M, "Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors", J Rheumatol, 32(5), pp.906~912 (2005)
- Oda M, "Loss of urate oxidase activity in hominoids and its evolutionary implications", Mol Biol Evol, 19(5), pp.640~653 (2002)[DOI]
- Kim JW, "Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015", Rheumatol Int, 37(9), pp.1499~1506 (2017)[DOI]
- Chen H, "Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study", Am J Epidemiol, 169(9), pp.1064~1069 (2009)[DOI]
- Annanmaki T, "Uric acid associates with cognition in Parkinson's disease", Parkinsonism Relat Disord, 14(7), pp.576~578 (2008)[DOI]
- Glantzounis GK, "Uric acid and oxidative stress", Curr Pharm Des, 11(32), pp.4145~4151 (2005)[DOI]
- Choi HK, "Independent impact of gout on mortality and risk for coronary heart disease", Circulation, 116(8), pp.894~900 (2007)[DOI]
- Chen JH, "Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study", Arthritis Rheum, 61(2), pp.225~232 (2009)[DOI]
- Nakanishi N, "Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers", Eur J Epidemiol, 18(6), pp.523~530 (2003)
- Kawashima M, "Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study", BMC Nephrol, 12, pp.31~ (2011)[DOI]
- Madero M, "Uric acid and long-term outcomes in CKD", Am J Kidney Dis, 53(5), pp.796~803 (2009)[DOI]
- Sturm G, "Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study", Exp Gerontol, 43(4), pp.347~352 (2008)[DOI]
- Nashar K, "Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?", Adv Chronic Kidney Dis, 19(6), pp.386~391 (2012)[DOI]
- Goicoechea M, "Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial", Am J Kidney Dis, 65(4), pp.543~549 (2015)[DOI]
- Kanda E, "Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study", PLoS One, 10(2), pp.e0118031~ (2015)[DOI]
- Suliman ME, "J-shaped mortality relationship for uric acid in CKD", Am J Kidney Dis, 48(5), pp.761~771 (2006)[DOI]
- Lee SM, "Low serum uric acid level is a risk factor for death in incident hemodialysis patients", Am J Nephrol, 29(2), pp.79~85 (2009)[DOI]
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150(9), pp.604~612 (2009)[DOI]
- Toyama T, "Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with normal or mildly reduced kidney function", PLoS One, 10(9), pp.e0137449~ (2015)[DOI]
- Fang J, "Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey", JAMA, 283(18), pp.2404~2410 (2000)[DOI]
- Chonchol M, "Relationship of uric acid with progression of kidney disease", Am J Kidney Dis, 50(2), pp.239~247 (2007)[DOI]
- Johnson RJ, "Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?", J Am Soc Nephrol, 16(7), pp.1909~1919 (2005)[DOI]
- Sanchez-Lozada LG, "Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia", Am J Physiol Renal Physiol, 295(4), pp.F1134~F1141 (2008)[DOI]
- Kim IY, "The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship", Biomed Res Int, 2014, pp.638732~ (2014)
- Wang S, "Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan", Nephrology (Carlton), 16(8), pp.767~776 (2011)[DOI]
- Bellomo G, "Uric acid: the lower the better?", Contrib Nephrol, 192, pp.69~76 (2018)
- Ohta T, "Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature", Clin Nephrol, 58(4), pp.313~316 (2002)[DOI]
- Kikuchi Y, "Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction", Clin Nephrol, 53(6), pp.467~472 (2000)
- Coca SG, "Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis", Kidney Int, 81(5), pp.442~448 (2012)[DOI]
- Kand'ar R, "Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography", Clin Chim Acta, 365(1-2), pp.249~256 (2006)[DOI]
- Nishizaki N, "Hereditary renal hypouricemia: a cause of calcium oxalate urolithiasis in a young female", Clin Nephrol, 77(2), pp.161~163 (2012)[DOI]
- Tanaka Y, "The influence of serum uric acid on renal function in patients with calcium or uric acid stone: a population-based analysis", PLoS One, 12(7), pp.e0182136~ (2017)[DOI]
- Chang Y, "Metabolically healthy obesity and development of chronic kidney disease: a cohort study", Ann Intern Med, 164(5), pp.305~312 (2016)[DOI]
- Mumford SL, "Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study", Hum Reprod, 28(7), pp.1853~1862 (2013)[DOI]
- Takiue Y, "The effect of female hormones upon urate transport systems in the mouse kidney", Nucleosides Nucleotides Nucleic Acids, 30(2), pp.113~119 (2011)[DOI]
- Bash LD, "Defining incident chronic kidney disease in the research setting: the ARIC Study", Am J Epidemiol, 170(4), pp.414~424 (2009)[DOI]